The genomic landscape of CYP2D6 variation in the Indian population

被引:0
|
作者
Sivadas, Ambily [1 ]
Rathore, Surabhi [2 ,3 ]
Sahana, S. [2 ,3 ]
Jolly, Bani [2 ,3 ]
Bhoyar, Rahul C. [2 ]
Jain, Abhinav [2 ,3 ]
Sharma, Disha [2 ]
Imran, Mohamed [2 ,3 ]
Senthilvel, Vigneshwar [2 ,3 ]
Divakar, Mohit Kumar [2 ,3 ]
Mishra, Anushree [2 ,3 ]
Sivasubbu, Sridhar [2 ,3 ,4 ]
Scaria, Vinod [2 ,3 ,4 ]
机构
[1] St Johns Natl Acad Hlth Sci, Div Nutr, St Johns Res Inst, Bangalore 560034, Karnataka, India
[2] CSIR, Inst Genom & Integrat Biol, Mathura Rd, New Delhi 110025, India
[3] Acad Sci & Innovat Res AcSIR, Ghaziabad 201002, Uttar Pradesh, India
[4] Vishwanath Canc Care Fdn, B 702,7th Floor,Neelkanth Business Pk Kirol Villag, Vidya Vihar 400086, West Mumbai, India
关键词
cytochrome P450; drug metabolism; genomics; Indian population; molecular dynamics simulation; personalized medicine; pharmacogenomics; pharmacology; polymorphism; DRUG-METABOLIZING-ENZYMES; GENETIC-POLYMORPHISM; POOR METABOLIZERS; CRYSTAL-STRUCTURE; IN-SILICO; WILD-TYPE; DEBRISOQUINE; VARIANTS; IDENTIFICATION; FREQUENCY;
D O I
10.2217/pgs-2023-0233
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: The CYP2D6 gene is highly polymorphic, causing large interindividual variability in the metabolism of several clinically important drugs. Materials & methods: The authors investigated the diversity and distribution of CYP2D6 alleles in Indians using whole genome sequences (N = 1518). Functional consequences were assessed using pathogenicity scores and molecular dynamics simulations. Results: The analysis revealed population-specific CYP2D6 alleles (*86, *7, *111, *112, *113, *99) and remarkable differences in variant and phenotype frequencies with global populations. The authors observed that one in three Indians could benefit from a dose alteration for psychiatric drugs with accurate CYP2D6 phenotyping. Molecular dynamics simulations revealed large conformational fluctuations, confirming the predicted reduced function of *86 and *113 alleles. Conclusion: The findings emphasize the utility of comprehensive CYP2D6 profiling for aiding precision public health.
引用
收藏
页码:147 / 160
页数:14
相关论文
共 50 条
  • [1] Resequencing CYP2D6 gene in Indian population: CYP2D6*41 identified as the major reduced function allele
    Manoharan, Aarthi
    Shewade, Deepak Gopal
    Ravindranath, Pradeep Anand
    Rajkumar, Ravi Philip
    Ramprasad, Vedam L.
    Adithan, Surendiran
    Damodaran, Solai Elango
    PHARMACOGENOMICS, 2019, 20 (10) : 719 - 730
  • [2] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [3] CYP2D6: novel genomic structures and alleles
    Kramer, Whitney E.
    Walker, Denise L.
    O'Kane, Dennis J.
    Mrazek, David A.
    Fisher, Pamela K.
    Dukek, Brian A.
    Bruflat, Jamie K.
    Black, John L.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (10) : 813 - 828
  • [4] CYP2D6 phenotype and genotype in a Canadian Native Indian population
    Nowak, MP
    Tyndale, RF
    Sellers, EM
    PHARMACOGENETICS, 1997, 7 (02): : 145 - 148
  • [5] CYP2D6 Phenotyping Using Urine, Plasma, and Saliva Metabolic Ratios to Assess the Impact of CYP2D6*10 on Interindividual Variation in a Chinese Population
    Chen, Rui
    Zheng, Xin
    Hu, Pei
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [6] Characterization of CYP2D6 genotypes and metabolic profiles in the Portuguese population: pharmacogenetic implications
    Albuquerque, Jose
    Ribeiro, Carolina
    Naranjo, Maria Eugenia G.
    Llerena, Adrian
    Grazina, Manuela
    PERSONALIZED MEDICINE, 2013, 10 (07) : 709 - 718
  • [7] Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan
    Abduljalil, K.
    Frank, D.
    Gaedigk, A.
    Klaassen, T.
    Tomalik-Scharte, D.
    Jetter, A.
    Jaehde, U.
    Kirchheiner, J.
    Fuhr, U.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (05) : 643 - 651
  • [8] Genetic variations of human CYP2D6 in the Chinese Han population
    Qian, Jian-Chang
    Xu, Xin-Min
    Hu, Guo-Xin
    Dai, Da-Peng
    Xu, Ren-Ai
    Hu, Li-Ming
    Li, Fang-Hong
    Zhang, Xiu-Hua
    Yang, Jie-Fu
    Cai, Jian-Ping
    PHARMACOGENOMICS, 2013, 14 (14) : 1731 - 1743
  • [9] Polymorphisms of CYP2D6 in the Czech population.
    Slanar, Ondrej
    Buzkova, Helena
    Pechandova, Kristina
    Matouskova, Olga
    Perlik, Frantisek
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 232 - 232
  • [10] CYP2D6 genotypes in a Japanese population:: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10
    Nishida, Y
    Fukuda, T
    Yamamoto, I
    Azuma, J
    PHARMACOGENETICS, 2000, 10 (06): : 567 - 570